Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01894230 · ClinicalTrials.gov registry record · NA
Genetically Guided Statin Therapy
A NA study, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 167
- Enrollment target
NCT01894230: Completed NA study, sponsored by Duke University.
NCT01894230 is a NA study that has completed, run by Duke University. The registered enrollment target is 167 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01894230, a NA study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 167 participants
- Enrollment target
Study Summary
The purpose of this study is to examine if using genetics can improve statin adherence in patients who should be taking statins but are not because of prior side effects. This study will assist physicians/providers in making a personalized health care plan for prevention of cardiovascular disease.
Primary Outcome
The Morisky Medication Adherence Scale (MMAS) is a self-reported measure of adherence, collected at baseline for general medication and at 3 and 8 months of followup for statin specific adherence. The eight-item MMAS survey will be used. This is a modified version of the original four-item MMAS capturing further aspects of adherence behavior. The survey includes 8 yes/no items that are summed to create an overall adherence score ranging from of 0 to 8, with higher scores indicating better adhere
Interventions
- GENETIC SLCO1B1*5 allele testing, results reported at randomization
- GENETIC SLCO1B1*5 allele testing, results reported at end of study
- GENETIC Genetic testing for SLCO1B1*5 allele
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 167 participants |
| Start Date | 2013-07 |
| Est. Completion | 2016-04-30 |
| Phase | NA |
What the finished NCT01894230 record still lists
NCT01894230 is an interventional study that assigns participants to a tested intervention. The registered 167 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 3 interventions - of which SLCO1B1*5 allele testing, results reported at randomization is the first listed.
NCT01894230 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01894230 about?
NCT01894230 is a clinical study titled "Genetically Guided Statin Therapy". The purpose of this study is to examine if using genetics can improve statin adherence in patients who should be taking statins but are not because of prior side effects. This study will assist physicians/providers in making a personalized health care plan for prevention of cardiovascular disease.
What is the current status of trial NCT01894230?
This trial is currently completed. It is a NA study. The enrollment target is 167 participants. The study started on 2013-07. Estimated completion is 2016-04-30.
What interventions are being tested in trial NCT01894230?
The interventions under investigation include: SLCO1B1*5 allele testing, results reported at randomization (GENETIC), SLCO1B1*5 allele testing, results reported at end of study (GENETIC), Genetic testing for SLCO1B1*5 allele (GENETIC).
Who is sponsoring clinical trial NCT01894230?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01894230's enrollment target sits among peer trials
167 622nd of 2000 higher than 1,376 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04248283 · 167 participants · NA
Adjustable Continence Therapy (ACT) for the Treatment of Female SUI
- NCT04552509 · 167 participants · NA
TRUEBEAM Stereotactic Body Radiotherapy for Localized Prostate Cancer
- NCT05516277 · 167 participants · NA
Insomnia Treatment and Cardiometabolic Health in Older Adults With Posttraumatic Stress Disorder
- NCT02118922 · 168 participants
A Study to Test the Diagnostic Potential of Brillouin Microscopy for Corneal Ectasia
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia